ELATE OCULAR Trademark

Trademark Overview

On Friday, October 24, 2014, a trademark application was filed for ELATE OCULAR with the United States Patent and Trademark Office. The USPTO has given the ELATE OCULAR trademark a serial number of 86433951. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, June 2, 2025. This trademark is owned by Cambium Medical Technologies, LLC. The ELATE OCULAR trademark is filed in the Pharmaceutical Products category with the following description:

Therapeutic preparation sold as an integral component of biological eye drops
elate ocular

General Information

Serial Number86433951
Word MarkELATE OCULAR
Filing DateFriday, October 24, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, June 2, 2025
Registration Number5680816
Registration DateTuesday, February 19, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 12, 2015

Trademark Statements

Goods and ServicesTherapeutic preparation sold as an integral component of biological eye drops
NOT AVAILABLE"OCULAR"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 3, 2014
Primary Code005
First Use Anywhere DateFriday, September 26, 2014
First Use In Commerce DateFriday, September 26, 2014

Trademark Owner History

Party NameCambium Medical Technologies, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressAtlanta, GA 30319
Party NameCambium Medical Technologies, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressAtlanta, GA 30319
Party NameCambium Medical Technologies, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAtlanta, GA 303453718

Trademark Events

Event DateEvent Description
Tuesday, October 28, 2014NEW APPLICATION ENTERED
Wednesday, March 18, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 3, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 12, 2015ASSIGNED TO EXAMINER
Friday, February 13, 2015NON-FINAL ACTION WRITTEN
Friday, February 13, 2015NON-FINAL ACTION E-MAILED
Friday, February 13, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 18, 2015EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 18, 2015EXAMINERS AMENDMENT E-MAILED
Wednesday, March 18, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 18, 2015EXAMINER'S AMENDMENT ENTERED
Tuesday, July 7, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, November 20, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 21, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, April 7, 2015ASSIGNED TO LIE
Tuesday, April 7, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 22, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 12, 2015PUBLISHED FOR OPPOSITION
Tuesday, May 12, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, November 18, 2015SOU TEAS EXTENSION RECEIVED
Wednesday, November 18, 2015SOU EXTENSION 1 FILED
Wednesday, November 18, 2015SOU EXTENSION 1 GRANTED
Thursday, June 23, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 30, 2017SOU EXTENSION 4 FILED
Tuesday, June 21, 2016SOU EXTENSION 2 FILED
Tuesday, June 21, 2016SOU EXTENSION 2 GRANTED
Friday, December 16, 2016SOU TEAS EXTENSION RECEIVED
Friday, December 16, 2016SOU EXTENSION 3 FILED
Friday, December 16, 2016SOU EXTENSION 3 GRANTED
Tuesday, December 20, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 30, 2017SOU TEAS EXTENSION RECEIVED
Friday, June 30, 2017SOU EXTENSION 4 GRANTED
Tuesday, November 28, 2017SOU EXTENSION 5 FILED
Friday, December 1, 2017SOU EXTENSION 5 GRANTED
Wednesday, June 27, 2018STATEMENT OF USE PROCESSING COMPLETE
Friday, July 20, 2018SU - NON-FINAL ACTION - WRITTEN
Tuesday, July 4, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 28, 2017SOU TEAS EXTENSION RECEIVED
Friday, December 1, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, December 2, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 25, 2018TEAS STATEMENT OF USE RECEIVED
Monday, June 25, 2018USE AMENDMENT FILED
Friday, July 20, 2018NON-FINAL ACTION E-MAILED
Friday, July 20, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 16, 2019SU-EXAMINER'S AMENDMENT WRITTEN
Wednesday, January 16, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, January 16, 2019EXAMINER'S AMENDMENT ENTERED
Wednesday, January 16, 2019EXAMINERS AMENDMENT E-MAILED
Wednesday, January 16, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, January 17, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 19, 2019REGISTERED-PRINCIPAL REGISTER
Friday, February 7, 2025TEAS SECTION 8 & 15 RECEIVED
Monday, June 2, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, June 2, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, June 2, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, February 19, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

ocular elate biological drops component integral preparation sold therapeutic